Feasibility and Preliminary Efficacy of α-Calcium Sulfate Hemihydrate in Socket Preservation: Protocol for a Pilot Randomized Controlled Trial.

alveolar bone bone bone graft bone loss bone regeneration bone resorption dental dentist dentistry efficacy feasibility graft impacted tooth pilot radiographic imaging regeneration socket preservation tooth extraction α-CSH α–calcium sulfate hemihydrate

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
19 Jul 2024
Historique:
received: 13 06 2023
accepted: 23 04 2024
revised: 29 03 2024
medline: 19 7 2024
pubmed: 19 7 2024
entrez: 19 7 2024
Statut: epublish

Résumé

Tooth extraction procedures often lead to bone resorption, which can have adverse effects on the dimensions of the alveolar ridge. Research has shown that socket preservation techniques using bone graft substitutes can effectively minimize early bone loss in such cases. α-calcium sulfate hemihydrate (α-CSH) has garnered significant attention as a potential bone graft material due to its favorable properties, including osteoconductivity, angiogenic potential, and biocompatibility. Considering these facts, we developed a preliminary protocol for applying α-CSH in addressing alveolar bone loss following tooth extraction. This research's general objective is to evaluate the feasibility and initial effectiveness of α-CSH as bone-inducing graft material for socket preservation after tooth extraction. This preliminary clinical trial will involve 30 fresh extraction sockets from individuals aged 18-35 years. The participants will be divided into 2 groups: one group will receive α-CSH graft material after tooth extraction for socket preservation, while the other group will not receive any graft material. Throughout the study, the participants will be closely monitored for safety measures, which will include clinical examinations, radiographic imaging, and blood tests. Radiographic imaging will be used extensively to assist the progress of bone formation. The study commenced enrollment in August 2022 and is scheduled to conclude post assessments and analyses by the end of 2023. The results of the study are anticipated to be accessible in late 2024. This clinical study represents the initial investigation in humans to assess the feasibility and efficacy of α-CSH in alveolar bone regeneration. We hypothesize that the inclusion of α-CSH can greatly expedite the process of bone formation within fresh sockets, resulting in a swift restoration of bone height without the disadvantages associated with harvesting autogenous bone graft. Indonesia Registry Center INA-D02FAHP; https://tinyurl.com/2jnf6n3s. DERR1-10.2196/49922.

Sections du résumé

BACKGROUND BACKGROUND
Tooth extraction procedures often lead to bone resorption, which can have adverse effects on the dimensions of the alveolar ridge. Research has shown that socket preservation techniques using bone graft substitutes can effectively minimize early bone loss in such cases. α-calcium sulfate hemihydrate (α-CSH) has garnered significant attention as a potential bone graft material due to its favorable properties, including osteoconductivity, angiogenic potential, and biocompatibility. Considering these facts, we developed a preliminary protocol for applying α-CSH in addressing alveolar bone loss following tooth extraction.
OBJECTIVE OBJECTIVE
This research's general objective is to evaluate the feasibility and initial effectiveness of α-CSH as bone-inducing graft material for socket preservation after tooth extraction.
METHODS METHODS
This preliminary clinical trial will involve 30 fresh extraction sockets from individuals aged 18-35 years. The participants will be divided into 2 groups: one group will receive α-CSH graft material after tooth extraction for socket preservation, while the other group will not receive any graft material. Throughout the study, the participants will be closely monitored for safety measures, which will include clinical examinations, radiographic imaging, and blood tests. Radiographic imaging will be used extensively to assist the progress of bone formation.
RESULTS RESULTS
The study commenced enrollment in August 2022 and is scheduled to conclude post assessments and analyses by the end of 2023. The results of the study are anticipated to be accessible in late 2024.
CONCLUSIONS CONCLUSIONS
This clinical study represents the initial investigation in humans to assess the feasibility and efficacy of α-CSH in alveolar bone regeneration. We hypothesize that the inclusion of α-CSH can greatly expedite the process of bone formation within fresh sockets, resulting in a swift restoration of bone height without the disadvantages associated with harvesting autogenous bone graft.
TRIAL REGISTRATION BACKGROUND
Indonesia Registry Center INA-D02FAHP; https://tinyurl.com/2jnf6n3s.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/49922.

Identifiants

pubmed: 39028555
pii: v13i1e49922
doi: 10.2196/49922
doi:

Substances chimiques

Calcium Sulfate WAT0DDB505
Bone Substitutes 0

Types de publication

Journal Article Randomized Controlled Trial Clinical Trial Protocol

Langues

eng

Sous-ensembles de citation

IM

Pagination

e49922

Informations de copyright

©Muhammad Ruslin, Nurlindah Hamrun, Andi Tajrin, Andi Sitti Hajrah Yusuf, Rifaat Nurrahma, Diandra Sabrina Natsir-Kalla, Yossy Yoanita Ariestiana, Mukhtar Nur Anam, Chung-Ming Liu, Keng-Liang Ou. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 19.07.2024.

Auteurs

Muhammad Ruslin (M)

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia.

Nurlindah Hamrun (N)

Department of Oral Biology, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia.

Andi Tajrin (A)

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia.
Hasanuddin University Dental Hospital, Makassar, Indonesia.

Andi Sitti Hajrah Yusuf (ASH)

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia.

Rifaat Nurrahma (R)

Department of Prosthodontic, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia.
Department of Oral and Maxillofacial Surgery/Oral Pathology, Amsterdam University Medical Centers and Academic Centre for Dentistry Amsterdam, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, Netherlands.

Diandra Sabrina Natsir-Kalla (DS)

Department of Oral and Maxillofacial Surgery/Oral Pathology, Amsterdam University Medical Centers and Academic Centre for Dentistry Amsterdam, Vrije Universiteit Amsterdam, Amsterdam Movement Sciences, Amsterdam, Netherlands.
Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.

Yossy Yoanita Ariestiana (YY)

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia.

Mukhtar Nur Anam (M)

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Hasanuddin University, Makassar, Indonesia.

Chung-Ming Liu (CM)

Department of Biomedical Engineering, College of Biomedical Engineering, China Medical University, Taichung, Taiwan.

Keng-Liang Ou (KL)

Graduate Institute of Dental Science, College of Dentistry, China Medical University, Taichung, Taiwan.
Department of Dentistry, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan.
3D Global Biotech Inc (Spin-Off Company from Taipei Medical University), New Taipei City, Taiwan.
Department of Oral Hygiene Care, Ching Kuo Institute of Management and Health, Keelung, Taiwan.
Division of Clinical Cariology and Endodontology, Department of Oral Rehabilitation, School of Dentistry, Health Sciences University of Hokkaido, Hokkaido, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH